SAVANNAH BRADBURY: Open Payments
NPI 1326468059 · CONWAY, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$738 in 33 payments from 12 companies in 2025. Trend: 2023 $857 · 2024 $2,668 · 2025 $738
Food & beverage: $738
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 15 | $313 |
| Lundbeck LLC | 3 | $78 |
| Biogen, Inc. | 3 | $68 |
| ABBVIE INC. | 2 | $49 |
| Lilly USA, LLC | 2 | $39 |
| Neurocrine BioSciences, Inc. | 2 | $36 |
| JAZZ PHARMACEUTICALS INC. | 1 | $34 |
| UCB, Inc. | 1 | $33 |
| Amneal Pharmaceuticals LLC | 1 | $28 |
| TG Therapeutics, Inc. | 1 | $22 |
Products named: KESIMPTA, VYEPTI, VUMERITY, QULIPTA, INGREZZA, XYWAV, Rystiggo, CREXONT.
Industry payments across AR — which companies pay providers there.
